The Claim
In patients with cardiovascular disease, daily omega-3 fatty acid supplementation (≥1000 mg/day of EPA/DHA) is associated with a small but statistically significant increase in LDL cholesterol by 2.1 mg/dL, with no significant effect on triglycerides, HDL cholesterol, or Apo B.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with cardiovascular disease, taking at least 1000 mg per day of omega-3 fatty acids from EPA and DHA is linked to a small increase in LDL cholesterol by 2.1 mg/dL, with no measurable change in triglycerides, HDL cholesterol, or Apo B.
See the scientific wording
In patients with cardiovascular disease, daily omega-3 fatty acid supplementation (≥1000 mg/day of EPA/DHA) is associated with a small but statistically significant increase in LDL cholesterol by 2.1 mg/dL, while showing no significant effect on triglycerides, HDL, or Apo B, indicating a potential adverse lipid effect that may offset benefits in this population.
When people take high doses of omega-3 fatty acids, the liver uses them to make more fat-carrying particles that contain ApoB-100. These particles are released into the blood as LDL cholesterol, raising its level without changing the total number of these particles or affecting other cholesterol types.
What the research says
1 studyFor people with heart disease, taking omega-3 supplements slightly raised their 'bad' cholesterol (LDL) by about 2 points, without clearly helping other important cholesterol numbers — which might make the supplements less helpful than we thought.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.